290 related articles for article (PubMed ID: 36738240)
1. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Hu B; Tian T; Li XT; Hao PP; Liu WC; Chen YG; Jiang TY; Chen PS; Cheng Y; Xue FS
Redox Rep; 2023 Dec; 28(1):2158526. PubMed ID: 36738240
[TBL] [Abstract][Full Text] [Related]
2. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
[TBL] [Abstract][Full Text] [Related]
3. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
[TBL] [Abstract][Full Text] [Related]
4. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway.
He H; Liu P; Li P
Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane preconditioning alleviates myocardial ischemia reperfusion injury through mitochondrial NAD
Qin X; Qin Q; Ran K; Yuan G; Chang Y; Wang Y; Xiao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1108-1119. PubMed ID: 36097779
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway.
Zhao K; Tang J; Xie H; Liu L; Qin Q; Sun B; Qin ZH; Sheng R; Zhu J
Biomed Pharmacother; 2024 Jun; 175():116689. PubMed ID: 38703508
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
10. L-Carnitine Reduces Myocardial Oxidative Stress and Alleviates Myocardial Ischemia-Reperfusion Injury by Activating Nuclear Transcription-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) Signaling Pathway.
Zhao T; Chen S; Wang B; Cai D
Med Sci Monit; 2020 May; 26():e923251. PubMed ID: 32452468
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
Wu ZL; Davis JRJ; Zhu Y
Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
[TBL] [Abstract][Full Text] [Related]
14. Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis.
Zhai M; Li B; Duan W; Jing L; Zhang B; Zhang M; Yu L; Liu Z; Yu B; Ren K; Gao E; Yang Y; Liang H; Jin Z; Yu S
J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28500761
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in hyperlipidemic rats by inhibiting inflammation, oxidative stress and NF-κB.
Gao W; Du L; Li N; Li Y; Wu J; Zhang Z; Chen H
Chem Biol Drug Des; 2023 Nov; 102(5):1176-1185. PubMed ID: 37604597
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
[TBL] [Abstract][Full Text] [Related]
18. Effects of electroacupuncture with dexmedetomidine on myocardial ischemia/reperfusion injury in rats.
Zhang YJ; Lu SJ; Wang HY; Qi QL
Ann Palliat Med; 2022 Sep; 11(9):2916-2922. PubMed ID: 36217620
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis.
Qin Z; Xu Y
Protein Pept Lett; 2024; 31(2):116-127. PubMed ID: 38083898
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
